首页> 外文OA文献 >High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector
【2h】

High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector

机译:具有复制能力的腺病毒35型载体中两个独立表达盒的高水平表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Replication-incompetent adenovirus type 35 (rAd35) represents a potent vaccine carrier that elicits strong, antigen-specific T- and B-cell responses in diverse preclinical models. Moreover, Ad35 is rare in human populations, resulting in the absence of neutralizing antibodies against this carrier, in contrast to the commonly used rAd5. Therefore, rAd35 is being investigated as a vaccine carrier for a number of diseases for which an effective vaccine is needed, including malaria, AIDS and tuberculosis, However, it can be perceived that effective immunization will require insertion of multiple antigens into adenoviral vectors. We therefore wanted to create rAd35 vectors carrying double expression cassettes, to expand within one vector the number of insertion sites for foreign DNA encoding antigenic proteins. We show that it is possible to generate rAd35 vectors carrying two cytomegalovirus promoter-driven expression cassettes, provided that the polyadenylation signals in each expression cassette are not identical. We demonstrate excellent rAd35 vector stability and show that expression of a transgene is not influenced by the presence of a second expression cassette. Moreover, by using two model vaccine antigens, i.e. the human immunodeficiency virus-derived Env-gp120 protein and the Plasmodium falciparum-derived circumsporozoite protein, we demonstrate that potent T- and B-cell responses are induced to both antigens expressed from a single vector. Such rAd35 vectors thus expand the utility of rAd35 vaccine carriers for the development of vaccines against, for example, malaria, AIDS and tuberculosis
机译:无复制能力的35型腺病毒(rAd35)代表一种有效的疫苗载体,可在各种临床前模型中引发强烈的抗原特异性T细胞和B细胞反应。此外,与常用的rAd5相比,Ad35在人群中很少见,导致不存在针对该载体的中和抗体。因此,正在研究rAd35作为多种疾病的疫苗载体,这些疾病需要有效的疫苗,包括疟疾,艾滋病和结核病。但是,可以认为有效的免疫需要将多种抗原插入腺病毒载体中。因此,我们想要创建携带双重表达盒的rAd35载体,以在一个载体内扩展编码抗原蛋白的外源DNA的插入位点的数量。我们显示,只要每个表达盒中的聚腺苷酸信号不同,就有可能产生携带两个巨细胞病毒启动子驱动的表达盒的rAd35载体。我们证明了出色的rAd35载体稳定性,并表明转基因的表达不受第二个表达盒的存在的影响。此外,通过使用两种模型疫苗抗原,即人免疫缺陷病毒衍生的Env-gp120蛋白和恶性疟原虫衍生的环子孢子蛋白,我们证明了有效的T细胞和B细胞反应可诱导从单个载体表达的两种抗原。因此,此类rAd35载体扩大了rAd35疫苗载体在开发抗疟疾,艾滋病和肺结核疫苗方面的实用性

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号